Tehami Dermatology

    Skin infection guidance and antimicrobial stewardship

    Evidence-based decisions in impetigo, infected eczema, cellulitis and scabies.

    Updated: 2026-09-13

    Written for clinicians and medical students

    This section is a teaching reference for doctors, residents and medical students. It is not patient guidance and not a substitute for clinical examination, and it must not be used for self treatment.

    Stewardship decisions

    • For localised non-bullous impetigo in a systemically well patient, consider local antiseptic or topical antibiotic according to current local guidance; oral treatment is reserved for widespread, bullous or systemically significant disease [1].
    • An eczema flare with weeping or crusting is not always bacterial infection. In patients who are not systemically unwell, antibiotics add limited benefit to appropriate eczema treatment [2].
    • Cellulitis is usually unilateral, warm, tender and expanding. Bilateral red legs more often indicate venous or inflammatory disease and should trigger diagnostic reconsideration [3].
    • Treat scabies cases and close contacts together, repeat treatment when the product requires it, and address bedding and clothing according to public-health guidance [4].

    Local context

    Culture purulent, recurrent, treatment-resistant or outbreak-associated disease when results will alter care. Local resistance patterns, medicine availability and infection-control policies take priority over a foreign guideline.

    Sources

    1. [1] NICE NG153. Impetigo: antimicrobial prescribing.
    2. [2] NICE NG190. Secondary bacterial infection of eczema: antimicrobial prescribing.
    3. [3] NICE NG141. Cellulitis and erysipelas: antimicrobial prescribing.
    4. [4] WHO. Scabies fact sheet.

    By continuing to use this website, you accept our collection of the information necessary to provide our services. See our Privacy Policy.